T. Rowe Price Investment Management »

Denali Therapeutics shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $13M 647k 20.63
2023-06-30 $19M 647k 29.51
2023-03-31 $15M 647k 23.04
2022-12-31 $18M 633k 27.81